Registration and Continental Breakfast
Stern Lobby
Welcome and Introduction
Ash Tewari, MBBS, MCh, FRCS (Hon.), Dsc. (Hon.)
Cutting-Edge Approaches in Kidney Cancer: Advances in Imaging Techniques and Innovative Minimally Invasive Treatments
Ketan Badani, MD, FRCS (Hon.)
BREAK / Intro to Live Case
8:05 am
Surgeon: Ketan Badani, MD, FRCS (Hon.)
Moderator: Alexandre Mottrie (Prof.), MD, PhD
Panel: Simone Crivellaro, MD, MHA; Brian Shuch, MD; Craig Rogers, MD
BREAK / VISIT EXHIBITS
Moderator: Laurence Klotz, CM, MD
Panelists: Ash Tewari, MBBS, MCh; Peter Pinto, MD; Ming Zhou, MD, PhD; Samir S. Taneja, MD
Business, Economics, and Regulations in Urology
Deepak A. Kapoor, MD
Lancet Commission on Prostate Cancer
Nick James (Prof) MBBS, PhD
Online Misinformation About Prostate Cancer
Stacy Loeb, MD, MSc, PhD (Hon.)
Should We Keep Calling ISUP 1 Prostate Cancer?
Ming Zhou, MD, PhD
State-of-the-Art Lecture on Multicancer Early Detection
Eric Klein, MD
How to Use Polygenic Risk Ratios in Stratifying Patients for Prostate Cancer
Sujit Nair, PhD
Q&A
Moderator: Eric Klein, MD
Panelists: Neal Shore, MD, FACS; Mani Menon, MD; Laurence Klotz, CM, MD; Mitchell Benson, MD
TP Biopsy- The New Standard of Care
Jim Hu, MD, MPH
Use of Testosterone Replacement Therapy in Patients on Active Surveillance and Post PCa Treatment
Leon Telis, MD
Active Surveillance: When to Intervene and the Role of Imaging and Genomics
Peter Pinto, MD
Genomics and Clinical Significance of MR Visible vs Invisible Cancers
Laurence Klotz, CM, MD
Use of PSMA in Active Surveillance Risk Stratification - HOLOGRAM
Declan Murphy, MB, BCH, FRACS, FRCS (Urol)
Lunch / Visit Exhibits
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Himisha Beltran, MD, FRCS; Richard Stock, MD; Sujit S. Nair, PhD; Mitchell Benson, MD
Update on Prostatic Intra-Acinar Neoplasia: Precursors and Beyond
Angelo M. De Marzo, MD, PhD
Emerging Mechanisms of Treatment Resistance in Advance Prostate Cancer
Himisha Beltran, MD, FRCS
Biology of Prostate Cancer Metastases: Implications for Treatment
Simpa Salami, MD, MPH
Neoadjuvant Apalutamide and Downstaging Prostate Cancer
Isaac Yi Kim (Prof.), MD, PhD, MBA
Surgeon Scientist Journey in Advanced Prostate Cancer
Martin Gleave, MD
Q&A
Moderator: Isaac Yi Kim (Prof.), MD, PhD, MBA
Panel: Himisha Beltran, MD; Richard Stock, MD; Sujit S. Nair, PhD
National Prostate Cancer Screening in Sweden
Anna Lantz, MD, PhD
German Prostate Cancer Screening Trial PROBASE
Peter Albers, MD
Oncological Outcomes after Lymph Node Dissection vs No LND for High Risk Prostate Cancer
Peter Wiklund, MD, PhD
Intensification versus De-Intensification Strategies in Prostate Cancer
Neal Shore, MD, FACS
Prostate Cancer: Navigating the Landscape from HS to CRPC
Cora Sternberg (Prof.), MD, FACP
Moderator: Aditya Bagrodia, MD
Panel: Alessandro Volpe (Prof.), MD; Todd Morgan, MD; Michael Palese, MD
KEYNOTE LECTURE
Ketan Badani, MD, FRCS (Hon.)
The Evolving Management of Small Renal Masses: Advances in Active Surveillance and Future Perspectives
Craig Rogers, MD
Overview of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
Brian Shuch, MD
Modern Approach to Robotic Partial Nephrectomy for Hilar Tumors
Jihad Kaouk, MD
Q&A
Closing Remarks
Ketan Badani, MD, FRCS
Copyright © 2024 Prostate Cancer Symposium and World Urologic Oncology Symposium - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.